Literature DB >> 26994212

Modelling the distribution of health-related quality of life of advanced melanoma patients in a longitudinal multi-centre clinical trial using M-quantile random effects regression.

Riccardo Borgoni1, Paola Del Bianco2, Nicola Salvati3, Timo Schmid4, Nikos Tzavidis5.   

Abstract

Health-related quality of life assessment is important in the clinical evaluation of patients with metastatic disease that may offer useful information in understanding the clinical effectiveness of a treatment. To assess if a set of explicative variables impacts on the health-related quality of life, regression models are routinely adopted. However, the interest of researchers may be focussed on modelling other parts (e.g. quantiles) of this conditional distribution. In this paper, we present an approach based on quantile and M-quantile regression to achieve this goal. We applied the methodologies to a prospective, randomized, multi-centre clinical trial. In order to take into account the hierarchical nature of the data we extended the M-quantile regression model to a three-level random effects specification and estimated it by maximum likelihood.

Entities:  

Keywords:  Hierarchical data; Phase III study; Rotterdam Symptom Checklist; quantile regression; robust estimation

Mesh:

Year:  2016        PMID: 26994212     DOI: 10.1177/0962280216636651

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  2 in total

1.  Association of Access to Healthcare with Self-Assessed Health and Quality of Life among Old Adults with Chronic Disease in China: Urban Versus Rural Populations.

Authors:  Tao Zhang; Chaojie Liu; Ziling Ni
Journal:  Int J Environ Res Public Health       Date:  2019-07-20       Impact factor: 3.390

2.  Multidomain Social Determinants of Depressive Symptoms for the Elderly with Chronic Diseases: Evidence from the China Health and Retirement Longitudinal Study.

Authors:  Tao Zhang; Xiaohe Wang; Yongjian Xu
Journal:  Healthcare (Basel)       Date:  2021-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.